Utilizing electronic patient-reported outcome measures (ePROMs) may hold potential to reduce health care resource utilization without affecting outcomes for patients with inflammatory arthritides, such as rheumatoid arthritis.
Monitoring electronic patient-reported outcome measures (ePROMs) for patients with inflammatory arthritides (IAs) such as rheumatoid arthritis may help reduce health care resource utilization without negatively affecting disease outcomes, suggests a review published in Arthritis & Rheumatology.
IAs account for a large proportion of patients seen at rheumatology clinics, and consistent monitoring is key to optimize patient outcomes. In those with active disease, recommended management includes documentation of disease measures as often as monthly and drug therapy adjustment at least every 3 months, the authors explained. However, growing numbers of patients and the resulting demand on clinics can make regular monitoring difficult.
Therefore, their study assessed the potential of remote monitoring of ePROMs to help identify and intervene at times of disease activity, assist providers in making treatment decisions, and facilitate appropriate health care resource use. Digital health care can allow patients to take a more active role in their health, support self-monitoring and self-management of symptoms, and help clinicians understand disease activity over time between in-office visits.
Researchers combed through 5 databases (MEDLINE, Embase, PubMed, Cochrane Library, and Web of Science) to identify randomized controlled trials and nonrandomized controlled clinical trials. Eight studies, 7 of which assessed patients with rheumatoid arthritis, were included in the review. The studies included 4473 patients.
Meta-analyses and forest plots were done to assess the outcomes of interest, including difference in between-group disease activity scores and rates of remission, rates of treatment intensification, rates of disease flare, rates of face-to-face appointments, and telephone physician or total health care use between groups.
In the ePROM meta-analysis of 6 studies, disease activity was lower in the ePROM group vs the control group, with a standardized mean difference (SMD) of –0.15 (95% CI, -0.27 to -0.03). Although the change was small, the authors noted that none of the studies showed worsened disease activity among patients monitored via ePROMs.
The rates of remission or low disease activity were higher among the ePROM group in a meta-analysis of 5 studies, with an odds ratio (OR) of 1.65 (95% CI, 1.02-2.68). The remote ePROM cohort also needed fewer in-person visits (SMD, –0.93; 95% CI, –2.14 to 0.28) in a meta-anaylsis of 5 of the studies.
Notably, 5 of the studies included additional interventions along with ePROMs, such as disease education. Most of the studies were also at a high risk of bias and had significant heterogeneity, the authors wrote.
Despite limitations, the findings suggests that ePROM monitoring may be beneficial when managing patients with IAs, potentially mitigating health care resource utilization without having an impact on patient outcomes, the authors wrote.
“We cannot draw firm conclusions as to whether the use of remote ePROMs alone as an adjunct to usual care improves disease activity, as this was often used as part of a digital intervention with other combined features,” the authors concluded. “However, our data is suggestive of at least equivalent disease activity outcomes with using ePROM remote monitoring; importantly, there is no evidence to suggest worse outcomes with this method of asynchronous digital health care, and no detrimental impact in clinic attendance frequency with ePROMs.”
Reference
Arumalla N, Chan CKD, Gibson M, et al. The clinical impact of electronic patient-reported outcome measures in the remote monitoring of inflammatory arthritis: a systematic review and meta-analysis. Arthritis Rheumatol. Published online May 19, 2023. doi:10.1002/art.42559
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More